This trial will test if ravulizumab is an effective treatment for dermatomyositis, a disease that causes muscle weakness and skin rashes.
6 Primary · 45 Secondary · Reporting Duration: Week 2 through Week 50
Side Effects for
Awards & Highlights
2 Treatment Groups
1 of 2
1 of 2
150 Total Participants · 2 Treatment Groups
Primary Treatment: Ravulizumab · Has Placebo Group · Phase 2 & 3
Who is running the clinical trial?
Age 18+ · All Participants · 2 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Who else is applying?
What state do they live in?
How old are they?
|18 - 65||100.0%|
What site did they apply to?
|Clinical Trial Site||100.0%|
What portion of applicants met pre-screening criteria?
Frequently Asked Questions
What other data exists for Ravulizumab?
"Ravulizumab was first studied in 2016 at a clinical trial site. Since then, there have been 18245 completed trials. There are presently 16 actively recruiting trials, with many of these studies being performed in New York, New York." - Anonymous Online Contributor
Could you please list the various places where this research is conducted?
"There are 8 sites for this clinical trial, which are recruiting patients. The sites are located in New York, Orange and Baltimore, as well as 8 other locations. If you are considering participating, it would be helpful to choose the location nearest to you to reduce travel requirements." - Anonymous Online Contributor
What are some conditions that ravulizumab is used to treat?
"While Ravulizumab is most commonly used to treat disease activity, it can also help patients suffering from hemolysis, thrombotic microangiopathies, and atypical hemolytic uremic syndrome." - Anonymous Online Contributor
How many study participants are being sought for this research?
"That is correct. The clinical trial is currently recruiting participants, as indicated on clinicaltrials.gov. The listing was first posted on December 2nd, 2021 and was last updated on September 27th, 2022. The trial needs to enroll 150 patients at 8 different sites." - Anonymous Online Contributor
Are people still being recruited for this trial or has it been completed?
"Yes, this study is still looking for participants. According to the information on clinicaltrials.gov, the trial was first posted on December 2nd, 2021 and was last updated on September 27th, 2022." - Anonymous Online Contributor